During the current pandemic of COVID-19, numerous manifestations and complications have developed. As seen after the Second wave, patients with COVID-19 are at high risk of fungal infections, such as mucormycosis, that may result directly from COVID-19 infection and/or as a side effect of the drugs used in the COVID-19 treatment protocol. Rhino-orbito-cerebral mucormycosis is a fungal infection that can be fatal, especially in immunocompromised patients.
In this report, we described a series of 3 cases with frontal sinus osteomyelitis in post-COVID-19 diabetic patients diagnosed with mucormycosis.
Key words: COVID-19, Mucormycosis, Frontal Sinus, Osteomyelitis, Diabetes mellitus
|
